Nanette C. Joyce

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Craig M. McDonald, Erik Henricson, Richard T. Abresch et al. · The Lancet · 2017 · 475 citations

Medicine, Endocrinology, Neuromuscular Disorders +7

Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study

Luca Bello, Heather Gordish‐Dressman, Lauren P. Morgenroth et al. · Neurology · 2015 · 222 citations · Full text

Pharmacy, Pharmacotherapy, Rehabilitation Medicine +15

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

Michael G. Hanna, Umesh A. Badrising, Olivier Benvéniste et al. · The Lancet Neurology · 2019 · 133 citations · Full text

Life Sciences, Clinical Sciences, Immunology +16

Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy

Michela Guglieri, Kate Bushby, Michael McDermott et al. · JAMA · 2022 · 123 citations · Full text

Pharmacy, Pharmacotherapy, Pediatric Clinical Pharmacology +16

Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids

Craig M. McDonald, Heather Gordish‐Dressman, Erik Henricson et al. · Neuromuscular Disorders · 2018 · 117 citations · Full text

Health Professions, Clinical Sciences, Pharmacotherapy +16